Skip to main navigation

Skip to content

About Us
Team
Pipeline
Investors
News
Careers

About Us
Team
Pipeline
Investors
News
Careers

About Us
Team
Pipeline
Investors
News
Careers

About Us
Team
Pipeline
Investors
News
Careers

About Us
Team
Pipeline
Investors
News
Careers

About Us
Team
Pipeline
Investors
News
Careers

Overview
Press Releases
Events & Publications
Events & Presentations Publications
Financials
SEC Filings Annual Reports
Stock Info
Stock Quote & Chart Historical Price Lookup Analyst Coverage
Governance
Documents & Charters Management Team Board of Directors Committee Composition
Annual General Meeting
Shareholder Resources
FAQs Email Alerts Contact Us RSS Feeds
PFIC Information

Publications

February 18, 2021

Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma

Source

Ross, R., et al. BMJ Journals

January 6, 2020

Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling

Source

Woodhead, J.L., et al. PubMed

December 26, 2019

Lixivaptan, a New Generation Diuretic, Counteracts Vasopressin-Induced Aquaporin-2 Trafficking and Function in Renal Collecting Duct Cells

Source

Di Mise, A., et al. PubMed

May 22, 2019

Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model

Source

Wang, X., et al. PubMed

January 5, 2017

Design and characterization of an APC-specific serpin for the treatment of hemophilia

Source

Polderdijk, S., et al. Blood

Print Page

FAQs

Email Alerts

Contact Us

RSS Feeds

About Us
Team
Pipeline
Pipeline
Ongoing Clinical Trials
Expanded Access Policy
Investors
News
Careers

Menu

About Us
Team
Pipeline
Pipeline
Ongoing Clinical Trials
Expanded Access Policy
Investors
News
Careers

Site - Footer - Bottom Nav

Privacy Notices
PFIC Information

Follow Us

Scroll to Top